{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:09:22Z","timestamp":1789150162217,"version":"build-2803163510"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T00:00:00Z","timestamp":1775952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Small cell lung cancer (SCLC) patients frequently experience a remarkable response to first-line therapy. Follow up maintenance treatments aim to control residual tumor cells, but generally fail due to cross-resistance, inefficient targeting of tumor vulnerabilities, or dose-limiting toxicity, resulting in relapse and disease progression. Here we show that SCLC cells, similar to their cells of origin, pulmonary neuroendocrine cells, exhibit low activity in pathways protecting against reactive oxygen species (ROS). When exposed to a thioredoxin reductase 1 (TXNRD1) inhibitor, these cells quickly exhaust their ROS-scavenging capacity, regardless of their molecular subtype or resistance to first-line therapy. Importantly, unlike non-cancerous cells, SCLC cells cannot adapt to drug-induced ROS stress due to the suppression of ROS defense mechanisms by multiple layers of gene regulation. By exploiting this difference in oxidative stress management, we safely increase the therapeutic dose of TXNRD1 inhibitors in vivo by pharmacological activation of the NRF2 stress response pathway. This results in improved tumor control without added toxicity to healthy tissues. These findings underscore the therapeutic potential of TXNRD1 inhibitors for maintenance therapy in SCLC.<\/jats:p>","DOI":"10.1038\/s41467-026-71608-4","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T22:36:21Z","timestamp":1775946981000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Differential KEAP1\/NRF2 mediated signaling widens the therapeutic window of redox-targeting drugs in SCLC therapy"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5490-0747","authenticated-orcid":false,"given":"Jana","family":"Samarin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5562-9207","authenticated-orcid":false,"given":"Hana","family":"N\u016fskov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6101-7995","authenticated-orcid":false,"given":"Piotr","family":"Fabrowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Malz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eberhard","family":"Amtmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minerva J.","family":"Taeubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Pastor-Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8187-3281","authenticated-orcid":false,"given":"Daniel","family":"Kazdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Kurilov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3576-6431","authenticated-orcid":false,"given":"Nicole","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannelore","family":"Pink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2498-8315","authenticated-orcid":false,"given":"Franziska","family":"Deis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Hummel-Eisenbeiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Renz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamini","family":"Kaushal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9539-6404","authenticated-orcid":false,"given":"Michael","family":"Morgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1367-973X","authenticated-orcid":false,"given":"Tobias P.","family":"Dick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3778-510X","authenticated-orcid":false,"given":"Martina","family":"Muckenthaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1278-2594","authenticated-orcid":false,"given":"Moritz","family":"Mall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5688-3952","authenticated-orcid":false,"given":"Bryce","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2405-5527","authenticated-orcid":false,"given":"Taishi","family":"Kanamaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glynis","family":"Klinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin L.","family":"Sos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Frede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aubry K.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Alborzinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8116-2690","authenticated-orcid":false,"given":"Nikolas","family":"Gunkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,12]]},"reference":[{"key":"71608_CR1","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jtho.2015.10.008","volume":"11","author":"AG Nicholson","year":"2016","unstructured":"Nicholson, A. G. et al. The International association for the study of lung cancer lung cancer staging project: proposals for the revision of the clinical and pathologic staging of small cell lung cancer in the forthcoming eighth edition of the TNM classification for lung cancer. J. Thorac. Oncol. 11, 300\u2013311 (2016).","journal-title":"J. Thorac. Oncol."},{"key":"71608_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.21037\/tlcr.2018.01.16","volume":"7","author":"AF Farago","year":"2018","unstructured":"Farago, A. F. & Keane, F. K. Current standards for clinical management of small cell lung cancer. Transl. Lung Cancer Res. 7, 69\u201379 (2018).","journal-title":"Transl. Lung Cancer Res."},{"key":"71608_CR3","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1056\/NEJMoa1809064","volume":"379","author":"L Horn","year":"2018","unstructured":"Horn, L. et al. First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer. N. Engl. J. Med. 379, 2220\u20132229 (2018).","journal-title":"N. Engl. J. Med."},{"key":"71608_CR4","first-page":"620","volume":"73","author":"Z Megyesfalvi","year":"2023","unstructured":"Megyesfalvi, Z. et al. Clinical insights into small cell lung cancer: tumor heterogeneity, diagnosis, therapy, and future directions. CA Cancer J. Clin. 73, 620\u2013652 (2023).","journal-title":"CA Cancer J. Clin."},{"key":"71608_CR5","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1007\/s11912-023-01465-7","volume":"25","author":"S Canova","year":"2023","unstructured":"Canova, S. et al. Novel therapeutic options for small cell lung cancer. Curr. Oncol. Rep. 25, 1277\u20131294 (2023).","journal-title":"Curr. Oncol. Rep."},{"key":"71608_CR6","doi-asserted-by":"publisher","DOI":"10.1177\/1758835920977137","volume":"12","author":"T Landre","year":"2020","unstructured":"Landre, T. et al. First-line immune-checkpoint inhibitor plus chemotherapy versus chemotherapy alone for extensive-stage small-cell lung cancer: a meta-analysis. Ther. Adv. Med Oncol. 12, 1758835920977137 (2020).","journal-title":"Ther. Adv. Med Oncol."},{"key":"71608_CR7","doi-asserted-by":"publisher","first-page":"4652","DOI":"10.1158\/0008-5472.CAN-16-3502","volume":"77","author":"S Takagi","year":"2017","unstructured":"Takagi, S. et al. LSD1 inhibitor T-3775440 inhibits SCLC cell proliferation by disrupting LSD1 interactions with SNAG domain proteins INSM1 and GFI1B. Cancer Res. 77, 4652\u20134662 (2017).","journal-title":"Cancer Res."},{"key":"71608_CR8","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.1158\/1078-0432.CCR-22-1128","volume":"28","author":"JB Hiatt","year":"2022","unstructured":"Hiatt, J. B. et al. Inhibition of LSD1 with bomedemstat sensitizes small cell lung cancer to immune checkpoint blockade and T-cell killing. Clin. Cancer Res. 28, 4551\u20134564 (2022).","journal-title":"Clin. Cancer Res."},{"key":"71608_CR9","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1002\/1878-0261.13124","volume":"16","author":"W Yan","year":"2022","unstructured":"Yan, W. et al. Intrinsic and acquired drug resistance to LSD1 inhibitors in small cell lung cancer occurs through a TEAD4-driven transcriptional state. Mol. Oncol. 16, 1309\u20131328 (2022).","journal-title":"Mol. Oncol."},{"key":"71608_CR10","doi-asserted-by":"publisher","first-page":"5107","DOI":"10.1158\/1078-0432.CCR-18-4140","volume":"25","author":"MD Chalishazar","year":"2019","unstructured":"Chalishazar, M. D. et al. MYC-driven small-cell lung cancer is metabolically distinct and vulnerable to arginine depletion. Clin. Cancer Res. 25, 5107\u20135121 (2019).","journal-title":"Clin. Cancer Res."},{"key":"71608_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41572-020-00235-0","volume":"7","author":"CM Rudin","year":"2021","unstructured":"Rudin, C. M., Brambilla, E., Faivre-Finn, C. & Sage, J. Small-cell lung cancer. Nat. Rev. Dis. Prim. 7, 3 (2021).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"71608_CR12","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1097\/JTO.0b013e3181ec1713","volume":"5","author":"GA Otterson","year":"2010","unstructured":"Otterson, G. A., Hodgson, L., Pang, H. & Vokes, E. E. Cancer, Leukemia Group B. Phase II study of the histone deacetylase inhibitor Romidepsin in relapsed small cell lung cancer (Cancer and Leukemia Group B 30304). J. Thorac. Oncol. 5, 1644\u20131648 (2010).","journal-title":"J. Thorac. Oncol."},{"key":"71608_CR13","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1097\/JTO.0b013e318293d88c","volume":"8","author":"F de Marinis","year":"2013","unstructured":"de Marinis, F. et al. A phase II study of the histone deacetylase inhibitor panobinostat (LBH589) in pretreated patients with small-cell lung cancer. J. Thorac. Oncol. 8, 1091\u20131094 (2013).","journal-title":"J. Thorac. Oncol."},{"key":"71608_CR14","first-page":"533","volume":"4","author":"H Mamdani","year":"2015","unstructured":"Mamdani, H., Induru, R. & Jalal, S. I. Novel therapies in small cell lung cancer. Transl. Lung Cancer Res. 4, 533\u2013544 (2015).","journal-title":"Transl. Lung Cancer Res."},{"key":"71608_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102639","volume":"62","author":"J Samarin","year":"2023","unstructured":"Samarin, J. et al. Low level of antioxidant capacity biomarkers but not target overexpression predicts vulnerability to ROS-inducing drugs. Redox Biol. 62, 102639 (2023).","journal-title":"Redox Biol."},{"key":"71608_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.devcel.2020.09.024","volume":"55","author":"J Xu","year":"2020","unstructured":"Xu, J., Yu, H. & Sun, X. Less is more: rare pulmonary neuroendocrine cells function as critical sensors in lung. Dev. Cell 55, 123\u2013132 (2020).","journal-title":"Dev. Cell"},{"key":"71608_CR17","doi-asserted-by":"publisher","first-page":"12156","DOI":"10.1002\/chem.202101366","volume":"27","author":"M Morgen","year":"2021","unstructured":"Morgen, M., Fabrowski, P., Amtmann, E., Gunkel, N. & Miller, A. K. Inclusion complexes of gold(I)-dithiocarbamates with beta-cyclodextrin: a journey from drug repurposing towards drug discovery. Chem. Eur. J. 27, 12156\u201312165 (2021).","journal-title":"Chem. Eur. J."},{"key":"71608_CR18","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41589-020-0501-5","volume":"16","author":"JK Eaton","year":"2020","unstructured":"Eaton, J. K. et al. Selective covalent targeting of GPX4 using masked nitrile-oxide electrophiles. Nat. Chem. Biol. 16, 497\u2013506 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"71608_CR19","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.ccell.2017.01.006","volume":"31","author":"EE Gardner","year":"2017","unstructured":"Gardner, E. E. et al. Chemosensitive relapse in small cell lung cancer proceeds through an EZH2-SLFN11 axis. Cancer Cell 31, 286\u2013299 (2017).","journal-title":"Cancer Cell"},{"key":"71608_CR20","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/CAD.0000000000001267","volume":"33","author":"B Rath","year":"2022","unstructured":"Rath, B. et al. Rovalpituzumab tesirine resistance: analysis of a corresponding small cell lung cancer and circulating tumor cell line pair. Anticancer Drugs 33, 300\u2013307 (2022).","journal-title":"Anticancer Drugs"},{"key":"71608_CR21","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s43018-019-0020-z","volume":"1","author":"CA Stewart","year":"2020","unstructured":"Stewart, C. A. et al. Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer. Nat. Cancer 1, 423\u2013436 (2020).","journal-title":"Nat. Cancer"},{"key":"71608_CR22","doi-asserted-by":"publisher","first-page":"28575","DOI":"10.18632\/oncotarget.15338","volume":"8","author":"C Allison Stewart","year":"2017","unstructured":"Allison Stewart, C. et al. Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer. Oncotarget 8, 28575\u201328587 (2017).","journal-title":"Oncotarget"},{"key":"71608_CR23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41420-025-02328-9","volume":"11","author":"G Eskander","year":"2025","unstructured":"Eskander, G., Abdelhamid, S. G., Wahdan, S. A. & Radwan, S. M. Insights on the crosstalk among different cell death mechanisms. Cell Death Discov. 11, 56 (2025).","journal-title":"Cell Death Discov."},{"key":"71608_CR24","doi-asserted-by":"publisher","first-page":"14376","DOI":"10.1073\/pnas.97.26.14376","volume":"97","author":"S Sperandio","year":"2000","unstructured":"Sperandio, S., de Belle, I. & Bredesen DE An alternative, nonapoptotic form of programmed cell death. Proc. Natl. Acad. Sci. USA 97, 14376\u201314381 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"71608_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05586-6","volume":"14","author":"MJ Seo","year":"2023","unstructured":"Seo, M. J. et al. Dual inhibition of thioredoxin reductase and proteasome is required for auranofin-induced paraptosis in breast cancer cells. Cell Death Dis. 14, 42 (2023).","journal-title":"Cell Death Dis."},{"key":"71608_CR26","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/s41420-024-01911-w","volume":"10","author":"YS Lin","year":"2024","unstructured":"Lin, Y. S. et al. Arnicolide D induces endoplasmic reticulum stress-mediated oncosis via ATF4 and CHOP in hepatocellular carcinoma cells. Cell Death Discov. 10, 134 (2024).","journal-title":"Cell Death Discov."},{"key":"71608_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ccell.2018.03.022","volume":"34","author":"M Rojo de la Vega","year":"2018","unstructured":"Rojo de la Vega, M., Chapman, E. & Zhang, D. D. NRF2 and the Hallmarks of Cancer. Cancer Cell 34, 21\u201343 (2018).","journal-title":"Cancer Cell"},{"key":"71608_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103134","volume":"72","author":"C Morgenstern","year":"2024","unstructured":"Morgenstern, C. et al. Biomarkers of NRF2 signalling: current status and future challenges. Redox Biol. 72, 103134 (2024).","journal-title":"Redox Biol."},{"key":"71608_CR29","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41589-020-0533-x","volume":"16","author":"JM Ghergurovich","year":"2020","unstructured":"Ghergurovich, J. M. et al. A small molecule G6PD inhibitor reveals immune dependence on pentose phosphate pathway. Nat. Chem. Biol. 16, 731\u2013739 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"71608_CR30","doi-asserted-by":"publisher","first-page":"23521","DOI":"10.1074\/jbc.M111.220178","volume":"286","author":"HJ Warnatz","year":"2011","unstructured":"Warnatz, H. J. et al. The BTB and CNC homology 1 (BACH1) target genes are involved in the oxidative stress response and in control of the cell cycle. J. Biol. Chem. 286, 23521\u201323532 (2011).","journal-title":"J. Biol. Chem."},{"key":"71608_CR31","doi-asserted-by":"publisher","first-page":"10228","DOI":"10.1093\/nar\/gks827","volume":"40","author":"Y Hirotsu","year":"2012","unstructured":"Hirotsu, Y. et al. Nrf2-MafG heterodimers contribute globally to antioxidant and metabolic networks. Nucleic Acids Res. 40, 10228\u201310239 (2012).","journal-title":"Nucleic Acids Res."},{"key":"71608_CR32","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11003","volume":"483","author":"J Barretina","year":"2012","unstructured":"Barretina, J. et al. The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483, 603\u2013607 (2012).","journal-title":"Nature"},{"key":"71608_CR33","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1042\/BJ20060076","volume":"398","author":"SA Osborne","year":"2006","unstructured":"Osborne, S. A. et al. The tert-butylhydroquinone-mediated activation of the human thioredoxin gene reveals a novel promoter structure. Biochem. J. 398, 269\u2013277 (2006).","journal-title":"Biochem. J."},{"key":"71608_CR34","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jprot.2014.05.007","volume":"108","author":"J Walsh","year":"2014","unstructured":"Walsh, J. et al. Identification and quantification of the basal and inducible Nrf2-dependent proteomes in mouse liver: biochemical, pharmacological and toxicological implications. J. Proteom. 108, 171\u2013187 (2014).","journal-title":"J. Proteom."},{"key":"71608_CR35","doi-asserted-by":"crossref","unstructured":"Borella, R. et al. Synthesis and anticancer activity of CDDO and CDDO-Me, two derivatives of natural triterpenoids. Molecules 24, 4097 (2019).","DOI":"10.3390\/molecules24224097"},{"key":"71608_CR36","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1089\/ars.2018.7509","volume":"28","author":"R Franco","year":"2018","unstructured":"Franco, R. & Vargas, M. R. Redox biology in neurological function, dysfunction, and aging. Antioxid. Redox Signal 28, 1583\u20131586 (2018).","journal-title":"Antioxid. Redox Signal"},{"key":"71608_CR37","doi-asserted-by":"crossref","unstructured":"Mirzaei, S. et al. Elucidating role of reactive oxygen species (ROS) in cisplatin chemotherapy: a focus on molecular pathways and possible therapeutic strategies. Molecules 26, 2382 (2021).","DOI":"10.3390\/molecules26082382"},{"key":"71608_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105575","volume":"167","author":"S Mirzaei","year":"2021","unstructured":"Mirzaei, S. et al. Nrf2 signaling pathway in cisplatin chemotherapy: potential involvement in organ protection and chemoresistance. Pharm. Res 167, 105575 (2021).","journal-title":"Pharm. Res"},{"key":"71608_CR39","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2174\/1566524019666190226104909","volume":"19","author":"J Zhou","year":"2019","unstructured":"Zhou, J., Li, Z., Li, J., Gao, B. & Song, W. Chemotherapy resistance molecular mechanism in small cell lung cancer. Curr. Mol. Med. 19, 157\u2013163 (2019).","journal-title":"Curr. Mol. Med."},{"key":"71608_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22336-4","volume":"12","author":"CM Bebber","year":"2021","unstructured":"Bebber, C. M. et al. Ferroptosis response segregates small cell lung cancer (SCLC) neuroendocrine subtypes. Nat. Commun. 12, 2048 (2021).","journal-title":"Nat. Commun."},{"key":"71608_CR41","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s00432-024-05653-1","volume":"150","author":"M Sakashita","year":"2024","unstructured":"Sakashita, M. et al. An algorithm-based technique for counting mitochondria in cells using immunohistochemical staining of formalin-fixed and paraffin-embedded sections. J. Cancer Res. Clin. Oncol. 150, 172 (2024).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"71608_CR42","doi-asserted-by":"crossref","unstructured":"Fuloria, S. et al. Comprehensive review of methodology to detect reactive oxygen species (ROS) in mammalian species and establish its relationship with antioxidants and cancer. Antioxidants 10, 128 (2021).","DOI":"10.3390\/antiox10010128"},{"key":"71608_CR43","doi-asserted-by":"crossref","unstructured":"Lewandowski, M. & Gwozdzinski, K. Nitroxides as antioxidants and anticancer drugs. Int J Mol Sci 18, 2490 (2017).","DOI":"10.3390\/ijms18112490"},{"key":"71608_CR44","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41589-022-01145-w","volume":"19","author":"U Barayeu","year":"2023","unstructured":"Barayeu, U. et al. Hydropersulfides inhibit lipid peroxidation and ferroptosis by scavenging radicals. Nat. Chem. Biol. 19, 28\u201337 (2023).","journal-title":"Nat. Chem. Biol."},{"key":"71608_CR45","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.tcb.2022.02.009","volume":"32","author":"HF Zhang","year":"2022","unstructured":"Zhang, H. F., Klein Geltink, R. I., Parker, S. J. & Sorensen, P. H. Transsulfuration, minor player or crucial for cysteine homeostasis in cancer. Trends Cell Biol. 32, 800\u2013814 (2022).","journal-title":"Trends Cell Biol."},{"key":"71608_CR46","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1164\/rccm.2206009","volume":"166","author":"PJ Kemp","year":"2002","unstructured":"Kemp, P. J. et al. Airway chemotransduction: from oxygen sensor to cellular effector. Am. J. Respir. Crit. Care Med 166, S17\u2013S24 (2002).","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"71608_CR47","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","volume":"38","author":"JD Hayes","year":"2020","unstructured":"Hayes, J. D., Dinkova-Kostova, A. T. & Tew, K. D. Oxidative stress in cancer. Cancer Cell 38, 167\u2013197 (2020).","journal-title":"Cancer Cell"},{"key":"71608_CR48","doi-asserted-by":"crossref","unstructured":"Lv, Y. et al. BRD4 targets the KEAP1-Nrf2-G6PD axis and suppresses redox metabolism in small cell lung cancer. Antioxidants 11, 661 (2022).","DOI":"10.3390\/antiox11040661"},{"key":"71608_CR49","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1038\/sj.bjc.6690268","volume":"79","author":"JK Kepa","year":"1999","unstructured":"Kepa, J. K. & Ross, D. DT-diaphorase activity in NSCLC and SCLC cell lines: a role for fos\/jun regulation. Br. J. Cancer 79, 1679\u20131684 (1999).","journal-title":"Br. J. Cancer"},{"key":"71608_CR50","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1124\/jpet.110.170084","volume":"335","author":"LM Aleksunes","year":"2010","unstructured":"Aleksunes, L. M. et al. Transcriptional regulation of renal cytoprotective genes by Nrf2 and its potential use as a therapeutic target to mitigate cisplatin-induced nephrotoxicity. J. Pharm. Exp. Ther. 335, 2\u201312 (2010).","journal-title":"J. Pharm. Exp. Ther."},{"key":"71608_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108637","volume":"112","author":"L Tomlinson","year":"2019","unstructured":"Tomlinson, L. et al. Attenuation of doxorubicin-induced cardiotoxicity in a human in vitro cardiac model by the induction of the NRF-2 pathway. Biomed. Pharmacother. 112, 108637 (2019).","journal-title":"Biomed. Pharmacother."},{"key":"71608_CR52","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.bbadis.2016.11.005","volume":"1863","author":"SM Ahmed","year":"2017","unstructured":"Ahmed, S. M., Luo, L., Namani, A., Wang, X. J. & Tang, X. Nrf2 signaling pathway: Pivotal roles in inflammation. Biochim. Biophys. Acta 1863, 585\u2013597 (2017).","journal-title":"Biochim. Biophys. Acta"},{"key":"71608_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-63482-x","volume":"10","author":"MS Ball","year":"2020","unstructured":"Ball, M. S. et al. CDDO-Me alters the tumor microenvironment in estrogen receptor negative breast cancer. Sci. Rep. 10, 6560 (2020).","journal-title":"Sci. Rep."},{"key":"71608_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.768753","volume":"13","author":"GM Torres","year":"2022","unstructured":"Torres, G. M. et al. T Cells and CDDO-Me attenuate immunosuppressive activation of human melanoma-conditioned macrophages. Front. Immunol. 13, 768753 (2022).","journal-title":"Front. Immunol."},{"key":"71608_CR55","doi-asserted-by":"crossref","unstructured":"Moerland, J. A. & Liby, K. T. The triterpenoid CDDO-methyl ester reduces tumor burden, reprograms the immune microenvironment, and protects from chemotherapy-induced toxicity in a preclinical mouse model of established lung cancer. Antioxidants 13, 621 (2024).","DOI":"10.3390\/antiox13060621"},{"key":"71608_CR56","doi-asserted-by":"publisher","first-page":"621","DOI":"10.2174\/1389203715666140530091910","volume":"15","author":"F Saccoccia","year":"2014","unstructured":"Saccoccia, F. et al. Thioredoxin reductase and its inhibitors. Curr. Protein Pept. Sci. 15, 621\u2013646 (2014).","journal-title":"Curr. Protein Pept. Sci."},{"key":"71608_CR57","doi-asserted-by":"crossref","unstructured":"Stafford, W. C. et al. Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy. Sci. Transl. Med. 10, eaaf7444 (2018).","DOI":"10.1126\/scitranslmed.aaf7444"},{"key":"71608_CR58","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1021\/jz500778t","volume":"5","author":"D Paliwoda","year":"2014","unstructured":"Paliwoda, D., Wawrzyniak, P. & Katrusiak, A. Unwinding Au(+) Au(+) bonded filaments in ligand-supported gold(I) polymer under pressure. J. Phys. Chem. Lett. 5, 2182\u20132188 (2014).","journal-title":"J. Phys. Chem. Lett."},{"key":"71608_CR59","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/BF00396382","volume":"113","author":"G Bepler","year":"1987","unstructured":"Bepler, G., Jaques, G., Koehler, A., Gropp, C. & Havemann, K. Markers and characteristics of human SCLC cell lines. Neuroendocrine markers, classical tumor markers, and chromosomal characteristics of permanent human small cell lung cancer cell lines. J. Cancer Res. Clin. Oncol. 113, 253\u2013259 (1987).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"71608_CR60","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00408-015-9725-7","volume":"193","author":"G Hamilton","year":"2015","unstructured":"Hamilton, G., Burghuber, O. & Zeillinger, R. Circulating tumor cells in small cell lung cancer: ex vivo expansion. Lung 193, 451\u2013452 (2015).","journal-title":"Lung"},{"key":"71608_CR61","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/ijc.27675","volume":"132","author":"F Castro","year":"2013","unstructured":"Castro, F. et al. High-throughput SNP-based authentication of human cell lines. Int. J. Cancer 132, 308\u2013314 (2013).","journal-title":"Int. J. Cancer"},{"key":"71608_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).","journal-title":"Sci. Rep."},{"key":"71608_CR63","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41586-020-2922-4","volume":"587","author":"KJ Travaglini","year":"2020","unstructured":"Travaglini, K. J. et al. A molecular cell atlas of the human lung from single-cell RNA sequencing. Nature 587, 619\u2013625 (2020).","journal-title":"Nature"},{"key":"71608_CR64","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jbiotec.2017.08.006","volume":"261","author":"E Reisinger","year":"2017","unstructured":"Reisinger, E. et al. OTP: an automatized system for managing and processing NGS data. J. Biotechnol. 261, 53\u201362 (2017).","journal-title":"J. Biotechnol."},{"key":"71608_CR65","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature14664","volume":"524","author":"J George","year":"2015","unstructured":"George, J. et al. Comprehensive genomic profiles of small cell lung cancer. Nature 524, 47\u201353 (2015).","journal-title":"Nature"},{"key":"71608_CR66","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1038\/ng.2405","volume":"44","author":"CM Rudin","year":"2012","unstructured":"Rudin, C. M. et al. Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer. Nat. Genet. 44, 1111\u20131116 (2012).","journal-title":"Nat. Genet."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71608-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71608-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71608-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T07:01:40Z","timestamp":1776063700000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71608-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,12]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["71608"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-71608-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,12]]},"assertion":[{"value":"23 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3435"}}